Comparison of multidimensional flow cytometry with standard morphology for evaluation of early marrow response in pediatric acute lymphoblastic leukemia

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 9, 2001, Pages 585-590

  Meshinchi, Soheil ^a,d   Thomson, Blythe ^b   Finn, Laura S ^a,d   Leisenring, Wendy ^a   Green, Cheri ^c   Radich, Jerald P ^a   Loken, Michael ^c   Hawkins, Douglas ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b INDIANA UNIVERSITY   (United States)

^c HEMATOLOGICS INC   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Acute lymphoblastic leukemia; Children; Morphology; Multidimensional flow cytometry

Indexed keywords

ANTILEUKEMIC AGENT;

ACCURACY; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW RESCUE; CELL STRUCTURE; CHILD; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INTERMETHOD COMPARISON; LEUKEMIA CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BONE MARROW EXAMINATION; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PREDICTIVE VALUE OF TESTS; RISK; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0035693627     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200112000-00007     Document Type: Article

References (30)

1. Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States: Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995; 75: 2186-95.
2. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605-15.
3. Miller RW, Young Jr., JL Novakovic B. Childhood cancer. Cancer 1995; 75: 395-405.
4. Buchanan GR, Rivera GK, Boyett JM, et al. Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study. Blood 1988; 72: 1286-92.
5. Gaynon PS, Qu RP, Chappell RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse: the Children’s Cancer Group Experience. Cancer 1998; 82: 1387-95.
6. King SC, Reiman RJ, Prosnitz LR. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin’s disease [see comments]. J Clin Oncol 1994; 12: 306-11.
7. Chauvet B, Felix-Faure C, Lupsascka N, et al. Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy. J Clin Oncol 1994; 12: 1402-7.
8. Keating MJ, Smith TL, Gehan EA, et al. Factors related to length of complete remission in adult acute leukemia. Cancer 1980; 45: 2017-29.
9. Kaplan WD, Jochelson MS, Herman TS, et al. Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 1990; 8: 1966-70.
10. Rautonen J, Hovi L, Siimes MA. Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia. Blood 1988; 71: 989-91.
11. Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patient. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-33.
12. Arico M, Basso G, Mandelli F, et al. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Cancer 1995; 75: 1684-93.
13. Miller DG. On the nature of susceptibility to cancer. The presidential address. Cancer 1980; 46: 1307-18.
14. Miller DR, Leikin S, Albo V, et al. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from children’s cancer study group. Cancer 1983; 51: 1041-9.
15. Gaynon PS, Desai AA, Bostrom BC, et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review. Cancer 1997; 80: 1717-26.
16. Gaynon PS, Bleyer WA, Steinherz PG, et al. Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Med Pediatr Oncol 1990; 18: 273-9.
17. Nachman JB, Sather HN, Sensel MG, et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy [see comments]. N Engl J Med 1998; 338: 1663-71.
18. Steinherz PG, Gaynon PS, Breneman JC, et al. Cytoreduction and prognosis in acute lymphoblastic leukemia-the importance of early marrow response: report from the Childrens Cancer Group [see comments]. J Clin Oncol 1996; 14: 389-98.
19. Schultz KR, Massing B, Spinelli JJ, et al. Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia [see comments]. Med Pediatr Oncol 1997; 29: 16-22.
20. Janossy G, Coustan-Smith E, Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia 1989; 3: 170-81.
21. Coustan-Smith E, Behm FG, Sanchez J, et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia [see comments]. Lancet 1998; 351: 550-4.
22. Sievers EL, Loken MR. Detection of minimal residual disease in acute myelogenous leukemia. J Pediatr Hematol Oncol 1995; 17: 123-33.
23. Wells DA, Sale GE, Shulman HM, et al. Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol 1998; 110: 84-94.
24. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia [see comments]. J Clin Oncol 1996; 14: 18-24.
25. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci 1993; 677: 265-80.
26. Wells DA, Sale GE, Shulman HM, et al. Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol 1998; 110: 84-94.
27. Hurwitz CA, Loken MR, Graham ML, et al. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 1988; 72: 299-307.
28. Stelzer GT, Shults KE, Wormsley SB, et al. Detection of occult lymphoma cells in bone marrow aspirates by multi-dimensional flow cytometry. Prog Clin Biol Res 1992; 377: 629-35.
29. Shulman HM, Wells D, Gooley T, et al. The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry. Am J Clin Pathol 1999; 112: 513-23.
30. Loken MR, Herzenber LA. Analysis of cell populations with a fluorescence-activated cell sorter. Ann N Y Acad Sci 1975; 254: 163-71.